Home
University & Research Institutions

Sector: University & Research Institutions

How a DNA sequencing start-up proved it is no pushover

TwinStrand co-founder’s grandfather famously didn’t patent the polio vaccine, but Dr Jesse Salk believes that protecting inventions is key to getting products to reach the market

Historic CRISPR drug approval heralds new era in Cas9 IP wars

Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.

CRISPR-Cas9 drugmakers like Vertex should come to the table early, says ToolGen’s IP chief

Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals

Latest content

Medical device maker is latest to tap secondary market for wireless patents

A recent deal shows that a wider selection of corporates are exploring acquisition opportunities and working with custom R&D labs

08 March 2022

Platform technology owners demand a chunk of Moderna’s covid-19 revenues

Arbutus Biopharma and Genevant Sciences have filed suit against the vaccine innovator

07 March 2022

Broad Institute’s big US CRISPR patent win does little to clear path for Cas9 licensees

As the US and European gene-editing IP landscapes drift further apart, therapeutics companies face difficult freedom-to-operate quandaries

03 March 2022

More is being done than ever before to monetise neglected pharma IP

Roivant’s most recent spinout shows that it is still on the hunt for deprioritised life sciences patents

22 February 2022

Lack of mRNA tech transfer “a blessing in disguise” for WHO vaccine team, says Afrigen boss

Petro Terblanche tells IAM about the IP issues surrounding her team’s new replica of Moderna’s covid-19 vaccine

10 February 2022

How platform technologies are reshaping life sciences IP value creation

Versatile biotechnologies are changing patterns of collaboration among healthcare innovators

10 February 2022

Latest Enlarged Board of Appeal referral is a must-watch for US applicants

EPO Board of Appeal seeks clarification on joint applicants approach to priority rights

04 February 2022

IPCom forms alliance with Chinese 5G lab Langbo

The pair say their strategic cooperation will start with in-house patent prosecution services with the potential to grow from there

02 February 2022

CRISPR IP deals continue apace despite legal battles

Spate of recent transactions show the value of gene-editing patents beyond Cas9

28 January 2022

Biden administration is right to pursue a ‘China Initiative’ reset

Even some of the programme’s architects seem to agree that it has strayed from initial focus on trade secrets and intellectual property

22 January 2022

Unlock unlimited access to all IAM content